Startup India Government of India
Medwaala Pharmaceuticals Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹57.45 Lakh
▲ 15% YoY
Net loss · FY 2024
₹61,971
Net margin -1.1%
EBITDA · FY 2024
₹60,154
EBITDA margin 1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Medwaala Pharmaceuticals Private Limited
Data last updated:
Medwaala Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 02 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL2017PTC310008. Its GSTIN is 07AAKCM7361F1ZA (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gurpreet Kaur and Gurmeet Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 19 F/F, Kh.No – 30/2 Main Wazirabad Road Brij Puri, Delhi, India – 110094.
As per the financials filed for FY 2024, the company reported a revenue of ₹57.45 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹61,971 (net margin -1.1%) and EBITDA of ₹60,154 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 43% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medwaala.com.
Company details
CIN U33119DL2017PTC310008
Registration Number 310008
Incorporation Date 02 January 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Gurpreet Kaur Director Gurmeet Singh Director Recognitions & Rankings of Medwaala Pharmaceuticals
Contact details
Medwaala Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is medwaala.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressA – 19 F/F, Kh.No – 30/2 Main Wazirabad Road Brij Puri, Delhi, India – 110094
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Medwaala Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medwaala Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medwaala Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medwaala Pharmaceuticals Private Limited, buy the company report.
Financials of Medwaala Pharmaceuticals Private Limited
FY 2025 filings availableMedwaala Pharmaceuticals Private Limited reported revenue of ₹57.45 Lakh (up 15% YoY) for FY 2024.
Revenue · FY 2024
₹57.45 Lakh ▲ 15%
Net loss · FY 2024
₹61,971 margin -1.1%
EBITDA · FY 2024
₹60,154 margin 1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 29%
5 years · compounded
▲ 43%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 83%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 15% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹60,154 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹61,971 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | -1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medwaala Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medwaala Pharmaceuticals Private Limited
Medwaala Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gurpreet Kaur | Director | 21 Feb 2020 | 6 Years 8 Months | Current |
| Gurmeet Singh | Director | 02 Jan 2017 | 9 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Medwaala Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medwaala Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medwaala Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCM7361F1ZA | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medwaala Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medwaala Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Gurpreet Kaur was appointed as Director on 21 Feb 2020.
AGM
Medwaala Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medwaala Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Gurpreet Kaur was appointed as Director.
Ceased
Rajeev Ranjan ceased to be Director.
Ceased
Paramjit Singh ceased to be Director.
Appointed
Gurmeet Singh was appointed as Director.
Incorporation
02 Jan 2017
Medwaala Pharmaceuticals Private Limited was registered on 02 Jan 2017 with Roc Delhi Ii & aged 9 years 10 months as per MCA records.
Frequently asked questions
Medwaala Pharmaceuticals is an active private limited company based in Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 02 January 2017 (9+ years old) and is registered under CIN U33119DL2017PTC310008.
Medwaala Pharmaceuticals has 2 current directors:
- Gurpreet Kaur - Director
- Gurmeet Singh - Director
The latest financial statements of Medwaala Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medwaala Pharmaceuticals is 07AAKCM7361F1ZA, registered in Delhi.
The CIN (Corporate Identification Number) of Medwaala Pharmaceuticals is U33119DL2017PTC310008. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medwaala Pharmaceuticals was incorporated on 02 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Gurpreet Kaur was appointed as Director on 21 Feb 2020. Rajeev Ranjan ceased to be Director on 21 Feb 2020. Paramjit Singh ceased to be Director on 28 Sep 2019. Medwaala Pharmaceuticals has 4 board changes on record in total.
Yes, Medwaala Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Medwaala Pharmaceuticals can be reached through the website medwaala.com. Its registered office is in Delhi, India.
The registered office of Medwaala Pharmaceuticals is at A – 19 FF, Kh.No – 302 Main Wazirabad Road Brij Puri, Delhi, India – 110094.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages